Has Raymond Rizzi, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $27,345 in general payments to Raymond Rizzi, DPM across 217 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raymond Rizzi, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raymond Rizzi, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raymond Rizzi, DPM

Foot & Ankle Surgery · Lees Summit, MONPI 1255337580

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (38.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 41 manufacturers reported payments, led by Organogenesis Inc. at 47.3% of the total. Reporting peaked in 2019 at $8,699 and has fallen 77.6% since, to $1,949 in 2025.

$27,345in general payments, 2019–2025

Across 217 payments — averaging $126.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Organogenesis Inc.$13K
Stryker$6K
Melinta Therapeutics, LLC$2K
Paragon 28, Inc.$2K
KCI USA, Inc.$1K
Zimmer Biomet$605
plus $3K from 35 others

What the payments were for

Consulting fees$3,00011%
Speaking & faculty fees$10,46638%
Travel & lodging$6,70625%
Food & beverage$6,41423%
Education$3981%
Gifts$3611%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Organogenesis Inc.	53	$12,943
Stryker(2 entities)	43	$5,792
Melinta Therapeutics, LLC	12	$2,062
Paragon 28, Inc.	7	$1,877
KCI USA, Inc.	5	$1,139
Zimmer Biomet	10	$605
Orthofix Medical, Inc.	5	$434
Smith+Nephew	17	$412
Abbott	3	$231
Integra Lifesciences Corporation	4	$193
Acera Surgical, Inc.	5	$154
Sanara Medtech Inc.	1	$151
Kerecis Limited	5	$151
Nevro Corp.	1	$146
Avita Medical Americas, LLC	3	$120
Misonix Inc	1	$110
Aroa Biosurgery Incorporated	3	$108
Polynovo North America LLC	3	$79
Titan Surgical Group, LLC	1	$70
Nabriva Therapeutics, PLC	4	$63
Kowa Pharmaceuticals America, Inc.	4	$53
AbbVie	3	$51
Sanofi	2	$49
Paratek Pharmaceuticals, Inc.	2	$33
Hydrofera LLC	1	$31
Solventum Corporation	1	$30
Merck	2	$29
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$28
Amgen	2	$23
Acumed LLC	1	$20
Access Pro Medical, LLC	1	$18
Collegium Pharmaceutical, Inc.	1	$17
3M Company	1	$17
Amarin Pharma, Inc.	1	$16
Takeda Pharmaceuticals U.S.A., Inc.	1	$15
AstraZeneca	1	$15
Mimedx Group, Inc.	1	$14
Treace Medical Concepts, Inc.	1	$14
Novo Nordisk	1	$11
Advanced Oxygen Therapy Inc.	1	$11
Vertiflex, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,345 in reported general payments places this provider in the 85th percentile of 163 foot & ankle surgery providers in Missouri.

See all foot & ankle surgery providers in Missouri →

Medicare billing

Part B allowed, 2024

$148,635

Medicare patients

290

Services billed

1,646

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Linezolid	12	$1,373
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	94	$565
Doxycycline Hyclate	60	$548
Clindamycin Hcl	56	$525
Terbinafine Hcl	27	$440
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	50	$432
Methylprednisolone	29	$190
Ciprofloxacin Hcl	21	$109
Hydroxyzine Hcl	15	$79
Amitriptyline Hcl	15	$76
Tramadol Hcl	31	$55
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	11	$49
Prednisone	13	$36

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Lees Summit

Amar PatelLees Summit$203K
Raquel SuginoLees Summit$77K
David MillwardLees Summit$61K
Alan ZonnoLees Summit$20K
Elliott WitykLees Summit$12K
Jeremy McCormickSaint Louis$1.5M
Jeffrey JohnsonSaint Louis$944K
Timothy BadweyKansas City$427K
Raymond AbdoSaint Louis$251K
Vincent SollecitoSaint Louis$221K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →